Advertising disclosure: we may earn a commission when you buy through links on this site. How we make money

HomeTrials › NCT07035093

Obesity & weight · Phase 3 · Recruiting now

A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain

NCT07035093 · Sponsor: Eli Lilly and Company

What this trial means for you

This study is recruiting now at 25 US sites. It's studying Retatrutide, Placebo for obesity, overweight, chronic low back pain (clbp).

Who can joinAll sexes, 18 Years and older
Healthy volunteersNo — diagnosis required
What you'd takeRetatrutide, Placebo
Study length~2.3 years overall
Planned participants586
TypeInterventional (you receive treatment)

What participants typically get: study medication (or placebo, if the trial uses one) and study-related medical care at no cost, plus close monitoring. Compensation for time and travel varies by study — ask the site. Note that in many trials you can't choose your treatment group, and some participants receive a placebo.

The study, in the sponsor's words

The main purpose of this study is to evaluate the efficacy and safety of retatrutide in relieving chronic low back pain in participants who have obesity or overweight. Participation in the study will last about 80 weeks.

Can you join? The exact criteria

Below is the verbatim eligibility text from the registry — bring it to your doctor; it's written for clinicians, and your own clinician is the right person to interpret it with you.

Full eligibility criteria (for you and your doctor)

Inclusion Criteria: * Have a history of axial-predominant low back pain * Have pain that is restricted to the low back or with a referral pattern limited to the proximal legs * Have a body mass index (BMI) ≥27 kilograms per square meter (kg/m2) at screening * Have a history of at least 1 self-reported unsuccessful dietary effort to lose body weight Exclusion Criteria: * Have a non-axial origin low back pain * Have had botulinum or steroid injections to the spine within 1 year of screening * Have had trigger point injection to the spine within 6 months of screening * Have a self-reported change in body weight \>5 kilograms (kg) (11 pounds) within 90 days prior to screening * Have been taking drugs to promote body weight reduction, including over-the-counter medications, within 90 days prior to screening * Have a prior or planned surgical treatment for obesity * Have Type 1 Diabetes, Type 2 Diabetes, or any other type of diabetes

Study sites by state

Arizona

  • MD First Research - Chandler — Chandler · Recruiting now
  • Tucson Orthopaedic Institute - North Wyatt Drive — Tucson · Recruiting now

California

  • Ark Clinical Research - Fountain Valley — Fountain Valley · Recruiting now
  • St Joseph Heritage Healthcare — Fullerton · Recruiting now
  • Clinical Research Institute — Los Angeles · Recruiting now
  • Artemis Institute for Clinical Research — San Diego · Recruiting now

Colorado

  • Alpine Clinical Research Center — Boulder · Recruiting now

Florida

  • K2 Medical Research - Daytona Beach — Daytona Beach · Recruiting now
  • Flourish Research - Miami, LLC — Miami · Recruiting now
  • IMA Clinical Research St. Petersburg — St. Petersburg · Recruiting now
  • Care Access - Tampa — Tampa · Recruiting now
  • Charter Research - Lady Lake — The Villages · Recruiting now
  • Conquest Research — Winter Park · Recruiting now

Kansas

  • Cotton O'Neil Clinical Research Center — Topeka · Recruiting now

Louisiana

  • Care Access - Lake Charles (Bayou Pines) — Lake Charles · Recruiting now

Massachusetts

  • MedVadis Research Corporation — Waltham · Recruiting now

Michigan

  • Great Lakes Research Group, Inc. — Bay City · Recruiting now

Missouri

  • Clinvest Headlands Llc — Springfield · Recruiting now

North Carolina

  • Center for Clinical Research — Winston-Salem · Recruiting now

Pennsylvania

  • Altoona Center For Clinical Research — Duncansville · Recruiting now

Tennessee

  • New Phase Research and Development — Knoxville · Recruiting now

Texas

  • FutureSearch Trials of Neurology — Austin · Recruiting now
  • Mercy Family Clinic — Dallas · Recruiting now
  • Houston Research Institute — Houston · Recruiting now

Virginia

  • Sovah Clinical Research-River District — Danville · Recruiting now

View the official record on ClinicalTrials.gov →

Verify before you act. Medical disclaimer: content on this site is for informational purposes only and is not medical advice. GLP-1 medications are prescription drugs; always consult a licensed healthcare provider about eligibility, risks, and benefits. Trial details and enrollment status change frequently — always verify on the official registry and talk to your own clinician before contacting a study site. This page was generated from registry data and is not affiliated with the study sponsor.

Follow this trial

Get an email when our monthly digest covers enrollment changes and results for trials like this one.

Newsletter signup launches soon. (Site owner: set PUBLIC_BUTTONDOWN_USERNAME in .env to activate this form.)

Keep researching on StudyBackedHealth